On Friday, Tenaya Therapeutics Inc (NASDAQ: TNYA) was -37.50% drop from the session before settling in for the closing price of $1.36. A 52-week range for TNYA has been $0.36 – $3.69.
Healthcare Sector giant saw their annual sales slid by -15.48% over the last five years. When this article was written, the company’s average yearly earnings per share was at 51.91%. With a float of $153.45 million, this company’s outstanding shares have now reached $163.74 million.
Tenaya Therapeutics Inc (TNYA) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Tenaya Therapeutics Inc stocks. The insider ownership of Tenaya Therapeutics Inc is 8.01%, while institutional ownership is 18.82%. The most recent insider transaction that took place on Nov 17 ’25, was worth 1,818. In this transaction SVP, Finance of this company sold 1,367 shares at a rate of $1.33, taking the stock ownership to the 93,971 shares. Before that another transaction happened on Nov 17 ’25, when Company’s Chief Medical Officer sold 2,877 for $1.33, making the entire transaction worth $3,826. This insider now owns 169,926 shares in total.
Tenaya Therapeutics Inc (TNYA) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.28 earnings per share (EPS) during the time that was better than consensus figure (set at -0.31) by 0.03. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.91% per share during the next fiscal year.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Trading Performance Indicators
You can see what Tenaya Therapeutics Inc (TNYA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.79, a number that is poised to hit -0.13 in the next quarter and is forecasted to reach -0.51 in one year’s time.
Technical Analysis of Tenaya Therapeutics Inc (TNYA)
Analysing the last 5-days average volume posted by the [Tenaya Therapeutics Inc, TNYA], we can find that recorded value of 14.75 million was better than the volume posted last year of 3.4 million. As of the previous 9 days, the stock’s Stochastic %D was 48.54%.
During the past 100 days, Tenaya Therapeutics Inc’s (TNYA) raw stochastic average was set at 12.16%, which indicates a significant increase from 9.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1047 in the past 14 days, which was lower than the 0.1218 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5014, while its 200-day Moving Average is $0.9423. Now, the first resistance to watch is $1.0050. This is followed by the second major resistance level at $1.1600. The third major resistance level sits at $1.2700. If the price goes on to break the first support level at $0.7400, it is likely to go to the next support level at $0.6300. Now, if the price goes above the second support level, the third support stands at $0.4750.
Tenaya Therapeutics Inc (NASDAQ: TNYA) Key Stats
There are 166,506K outstanding shares of the company, which has a market capitalization of 141.53 million. As of now, sales total 0 K while income totals -111,130 K. Its latest quarter income was 0 K while its last quarter net income were -20,280 K.
